<rdf:RDF xmlns:crm='http://www.cidoc-crm.org/rdfs/cidoc_crm_v5.0.2_english_label.rdfs#' xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:dcterms='http://purl.org/dc/terms/' xmlns:doap='http://usefulinc.com/ns/doap#' xmlns:edm='http://www.europeana.eu/schemas/edm/' xmlns:ekt='https://www.semantics.gr/authorities/schemanamespaces/ekt#' xmlns:foaf='http://xmlns.com/foaf/0.1/' xmlns:ore='http://www.openarchives.org/ore/terms/' xmlns:owl='http://www.w3.org/2002/07/owl#' xmlns:rdaGr2='http://rdvocab.info/ElementsGr2/' xmlns:rdf='http://www.w3.org/1999/02/22-rdf-syntax-ns#' xmlns:rdfs='http://www.w3.org/2000/01/rdf-schema#' xmlns:skos='http://www.w3.org/2004/02/skos/core#' xmlns:svcs='http://rdfs.org/sioc/services#' xmlns:wgs84_pos='http://www.w3.org/2003/01/geo/wgs84_pos#' xmlns:xalan='http://xml.apache.org/xalan'><edm:ProvidedCHO rdf:about='https://www.openarchives.gr/aggregator-openarchives/edm/dias/000058-100624'><dc:creator xml:lang='el'>Ζερβακης Μιχαηλ</dc:creator><dc:creator xml:lang='el'>Τσακανελη Σταυρουλα</dc:creator><dc:creator xml:lang='el'>Μπεη Αικατερινη</dc:creator><dc:creator xml:lang='en'>Bei Aikaterini</dc:creator><dc:creator xml:lang='en'>Tsakaneli Stavroula</dc:creator><dc:creator xml:lang='en'>Zervakis Michail</dc:creator><dc:description xml:lang='en'>Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects approximately 2.8 million persons globally. While there is currently no cure for this neurodegenerative disease, MS has become a highly manageable disease through treatment options like disease-modifying medications, that can help to control the symptoms and slow disease progression. Among them, interferon beta (IFNβ) therapy is a first-line treatment for MS but has shown to be only partially effective. Thus, it is important to identify biomarkers that aid in early identification of IFNβ responders. In this study, based on gene expression profiles from untreated and interferon treated patients from a publicly available dataset, we performed differential expression analysis and Pigengene network association (weighted correlation network analysis (WGCNA) and Bayesian networks modeling) in order to construct a high-confidence protein-protein (PPI) interaction network. Subsequently, aiming to find the most significant clustering modules and hub genes, we applied a number of topological analysis methods (cytoHubba plugin) followed by MCODE clustering algorithm. Our approach resulted in highly connected hub genes generating a reliable 21-hubgene signature that could predict the response of interferon beta (IFNβ) therapy in patients with MS. The 21-hub-gene signature showed high classification performance (Accuracy = 91,49%, Sensitivity = 94.55%, Specificity = 87.15%) demonstrating potential clinical benefit.</dc:description><dc:identifier>http://purl.tuc.gr/dl/dias/1DCC5A2B-CCD5-4B80-8E61-12EF753DDEA110.1109/BHI56158.2022.9926949 https://ieeexplore.ieee.org/document/9926949</dc:identifier><dc:language>eng</dc:language><dc:publisher xml:lang='en'>Institute of Electrical and Electronics Engineers</dc:publisher><dc:source xml:lang='el'>2022 IEEE-EMBS International Conference on Biomedical and Health Informatics</dc:source><dc:subject xml:lang='en'>Differentially expressed genes (DEGs)</dc:subject><dc:subject xml:lang='en'>LIMMA</dc:subject><dc:subject xml:lang='en'>Weighted correlation network analysis (WGCNA)</dc:subject><dc:subject xml:lang='en'>Multiple sclerosis (MS)</dc:subject><dc:subject xml:lang='en'>MCODE</dc:subject><dc:subject xml:lang='en'>Bayesian networks</dc:subject><dc:subject xml:lang='en'>Pigengene</dc:subject><dc:subject xml:lang='en'>cytoHubba</dc:subject><dc:subject xml:lang='en'>SAM</dc:subject><dc:subject xml:lang='en'>Interferon beta (INFβ)</dc:subject><dc:title xml:lang='en'>A 21-hub-gene signature in multiple sclerosis identified using machine learning techniques</dc:title><dc:type rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Conference-item'></dc:type><dc:type>full paper</dc:type><dc:type>conferenceItem</dc:type><dc:type rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Scientific-article'></dc:type><dcterms:created>2022</dcterms:created></edm:ProvidedCHO><skos:Concept rdf:about='http://semantics.gr/authorities/openarchives-item-types/Conference-item'><skos:prefLabel xml:lang='el'>Τεκμήριο συνεδρίου</skos:prefLabel><skos:prefLabel xml:lang='en'>Conference item</skos:prefLabel><skos:narrower rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Conference-proceedings'></skos:narrower><skos:narrower rdf:resource='http://semantics.gr/authorities/openarchives-item-types/-Conference-presentation'></skos:narrower><skos:narrower rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Conference-poster'></skos:narrower><skos:narrower rdf:resource='http://semantics.gr/authorities/openarchives-item-types/Conference-article'></skos:narrower></skos:Concept><skos:Concept rdf:about='http://semantics.gr/authorities/openarchives-item-types/Scientific-article'><skos:prefLabel xml:lang='el'>Επιστημονικό άρθρο</skos:prefLabel><skos:prefLabel xml:lang='en'>Scientific article</skos:prefLabel><skos:broader rdf:resource='http://semantics.gr/authorities/openarchives-item-types/arthro'></skos:broader></skos:Concept><ore:Aggregation rdf:about='https://www.openarchives.gr/aggregator-openarchives/edm/aggregation/provider/000058-100624%231'><edm:aggregatedCHO rdf:resource='https://www.openarchives.gr/aggregator-openarchives/edm/dias/000058-100624'></edm:aggregatedCHO><edm:dataProvider>Πολυτεχνείο Κρήτης</edm:dataProvider><edm:isShownAt rdf:resource='https://dias.library.tuc.gr/view/100624'></edm:isShownAt><edm:provider>Greek Aggregator OpenArchives.gr | National Documentation Centre (EKT)</edm:provider></ore:Aggregation></rdf:RDF>